SERB France
Acronym: SERB
General Information
Identification Code: 099063752858-61
Website: [object Object]
Entity Form: SAS
Registration Category: Companies & groups
Registration Date: 2/14/2024
EP Accredited Number: 0
Mission & Interests
Goals: SERB began in the 1950s in France as Société d’Études et de Recherches Biologiques (Company for Biologic Study and Research). Our portfolio of products, many of them lifesaving, is focused on emergency care and rare diseases. SERB has the broadest antidote portfolio in the world, including medical countermeasures for chemical, biological, radiological and nuclear (CBRN) risks. As a fully integrated company, we have the experience and capabilities to acquire, develop, and manufacture our medicines to the highest standards, and make them available worldwide through our secure supply chain.
Interests Represented: Promotes their own interests or the collective interests of their members
Interests:
- Business and industry
- Public health
- Research and innovation
Levels of Interest:
- national
- global
- european
Activities
Main EU Legislative Proposals: European healthcare policies, drug policies, industrial development. Contact with European institutions
Inter-institutional or Unofficial Groupings: N/A
Head Office
Address: 40 avenue George V
Post Code: 75008
City: Paris
Country: FRANCE
Phone: [object Object]
EU Office
Address: 40 avenue George V
Post Code: 75008
City: Paris
Country: FRANCE
Phone: [object Object]
Financial Data
New Organisation: false
Closed Year: [object Object]
Current Year: [object Object]
Membership Information
Members10 Percent: 0
Members25 Percent: 0
Members50 Percent: 0
Members75 Percent: 0
Members: 1
Members F T E: 1
Info Members: Head of Government Affairs EMEA
Structure
Structure Type: Structure
Organisation Members: SERB is a member of Leem and AMLIS in France